je.st
news
Johnson & Johnson: Rewarding Patient, Deep Analysis Oriented Investors
2015-10-21 21:10:12| Biotech - Topix.net
Johnson & Johnson, showing it's awareness from a shareholder sentiment standpoint, has approved a $10 billion share buyback program to reward patient and smart investors. I think if you can trust any company currently trading to navigate tough waters while also justifying investor patience and trust it's this one.
Tags: analysis
deep
johnson
patient
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||